NEW YORK (GenomeWeb) – Enterprise software company Aptean said yesterday that it has acquired GQ Life Sciences, a provider of life science patent search solutions, for an undisclosed amount.
GQ Life Sciences' flagship product, GenomeQuest, enables researchers to search for biological sequences across approximately 815,000 worldwide patents (or more than 345 million sequences). The company also recently launched LifeQuest, a specialized keyword search tool, which provides a wider range of users the ability to scan a dedicated database of more than 15 million life science patents.
"The acquisition of GQ Life Sciences expands our ability to provide vertically focused mission-critical enterprise solutions by entering the life sciences and big data markets where we see significant growth opportunities," Aptean CEO Kim Eaton said in a statement. "GQ Life Sciences leverages its deep expertise in biology, genomics, and semantics to deliver a best-in-class patent search solution, fueled by the world's largest database of biological sequences."